1. Home
  2. EMBC vs WSBCP Comparison

EMBC vs WSBCP Comparison

Compare EMBC & WSBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMBC
  • WSBCP
  • Stock Information
  • Founded
  • EMBC 1924
  • WSBCP N/A
  • Country
  • EMBC United States
  • WSBCP United States
  • Employees
  • EMBC N/A
  • WSBCP 2195
  • Industry
  • EMBC Medical/Dental Instruments
  • WSBCP Major Banks
  • Sector
  • EMBC Health Care
  • WSBCP Finance
  • Exchange
  • EMBC Nasdaq
  • WSBCP Nasdaq
  • Market Cap
  • EMBC 716.2M
  • WSBCP N/A
  • IPO Year
  • EMBC N/A
  • WSBCP N/A
  • Fundamental
  • Price
  • EMBC $13.30
  • WSBCP $25.01
  • Analyst Decision
  • EMBC Hold
  • WSBCP
  • Analyst Count
  • EMBC 3
  • WSBCP 0
  • Target Price
  • EMBC $17.67
  • WSBCP N/A
  • AVG Volume (30 Days)
  • EMBC 423.5K
  • WSBCP N/A
  • Earning Date
  • EMBC 05-09-2025
  • WSBCP N/A
  • Dividend Yield
  • EMBC 4.51%
  • WSBCP N/A
  • EPS Growth
  • EMBC 2.96
  • WSBCP N/A
  • EPS
  • EMBC 0.99
  • WSBCP N/A
  • Revenue
  • EMBC $1,107,700,000.00
  • WSBCP N/A
  • Revenue This Year
  • EMBC N/A
  • WSBCP N/A
  • Revenue Next Year
  • EMBC $0.99
  • WSBCP N/A
  • P/E Ratio
  • EMBC $13.44
  • WSBCP N/A
  • Revenue Growth
  • EMBC N/A
  • WSBCP N/A
  • 52 Week Low
  • EMBC $10.12
  • WSBCP N/A
  • 52 Week High
  • EMBC $21.48
  • WSBCP N/A
  • Technical
  • Relative Strength Index (RSI)
  • EMBC 60.26
  • WSBCP 41.25
  • Support Level
  • EMBC $12.08
  • WSBCP $24.86
  • Resistance Level
  • EMBC $12.76
  • WSBCP $25.08
  • Average True Range (ATR)
  • EMBC 0.50
  • WSBCP 0.07
  • MACD
  • EMBC 0.20
  • WSBCP -0.01
  • Stochastic Oscillator
  • EMBC 94.27
  • WSBCP 39.16

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About WSBCP WesBanco Inc. Depositary Shares Each Representing a 1/40th Interest in a Share of 6.75% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series A

Wesbanco Inc is a bank holding company. Through its subsidiaries, it offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. The company's reportable segments are Community Banking, which derives key revenue, and Trust and Investment Services. The Community Banking segment offers various banking products and services through various delivery channels, including commercial demand, individual demand, and time deposit accounts; commercial, mortgage, and individual installment loans; and certain non-traditional offerings, such as insurance and securities brokerage services.

Share on Social Networks: